• 1. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 5. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Toluenes

Introduction to 1-(2-methylphenyl)guanidine (CAS No: 37557-40-7)

1-(2-methylphenyl)guanidine, with the chemical formula C?H?N?, is a significant compound in the field of pharmaceutical and biochemical research. Its molecular structure incorporates a guanidine moiety attached to a 2-methylphenyl group, which contributes to its unique chemical properties and potential applications. This compound has garnered attention due to its role as an intermediate in the synthesis of various pharmacologically active molecules.

The CAS number 37557-40-7 provides a unique identifier for this substance, ensuring precise classification and reference in scientific literature and industrial applications. The guanidine functional group is well-known for its biological activity, often serving as a precursor in the development of drugs targeting bacterial infections, inflammation, and other metabolic disorders. The presence of the 2-methylphenyl group enhances the compound's solubility and interaction with biological targets, making it a valuable candidate for further exploration.

Recent advancements in medicinal chemistry have highlighted the importance of 1-(2-methylphenyl)guanidine in the design of novel therapeutic agents. Researchers have been particularly interested in its potential as a scaffold for developing inhibitors of enzymes involved in cancer progression. For instance, studies have demonstrated that derivatives of this compound can modulate the activity of tyrosine kinases, which are critical in signal transduction pathways associated with tumor growth. The methyl substituent on the phenyl ring appears to enhance binding affinity to these targets, improving the efficacy of potential drug candidates.

In addition to its applications in oncology, 1-(2-methylphenyl)guanidine has shown promise in addressing neurodegenerative diseases. Preliminary research indicates that this compound can interact with specific receptors in the brain, potentially mitigating symptoms associated with conditions such as Alzheimer's disease. The guanidine moiety's ability to cross the blood-brain barrier makes it an attractive moiety for developing central nervous system (CNS) drugs. Further investigation is warranted to fully elucidate its mechanisms of action and therapeutic potential.

The synthesis of 1-(2-methylphenyl)guanidine involves multi-step organic reactions, typically starting from readily available precursors such as 2-methylbenzaldehyde and guanidine hydrochloride. Advances in catalytic methods have enabled more efficient and scalable production processes, reducing costs and improving yields. These improvements are crucial for facilitating further research and commercialization efforts.

From a biochemical perspective, 1-(2-methylphenyl)guanidine exhibits interesting redox properties due to the presence of nitrogen heterocycles. This characteristic makes it a candidate for applications in bioelectrocatalysis and biosensors. Researchers are exploring its use in developing enzymes or cofactors that can facilitate electron transfer reactions in biotechnological systems. Such applications could have implications in renewable energy technologies and environmental monitoring.

The compound's stability under various conditions is another area of interest. Studies have examined its behavior under different pH levels, temperatures, and solvent systems to optimize its utility in synthetic protocols. Understanding these parameters is essential for ensuring consistent performance in both laboratory-scale experiments and large-scale industrial processes.

Regulatory considerations also play a role in the development and use of 1-(2-methylphenyl)guanidine. Compliance with safety standards and environmental regulations is necessary to ensure responsible handling and disposal. Manufacturers and researchers must adhere to guidelines set forth by agencies such as the FDA and EMA when evaluating new drug candidates or biochemical reagents.

Future research directions may focus on expanding the chemical diversity of derivatives derived from 1-(2-methylphenyl)guanidine. By introducing additional functional groups or varying substituents on the phenyl ring, scientists can tailor properties such as bioavailability, metabolic stability, and target specificity. Computational modeling techniques are increasingly being employed to predict structural modifications that could enhance drug-like characteristics.

The growing interest in green chemistry principles may also influence how 1-(2-methylphenyl)guanidine is synthesized and utilized. Efforts to minimize waste generation, reduce energy consumption, and employ sustainable raw materials are becoming integral parts of pharmaceutical development pipelines. Innovations in synthetic methodologies could align with these goals while maintaining high standards of quality control.

In conclusion,1-(2-methylphenyl)guanidine (CAS No: 37557-40-7) represents a versatile compound with significant potential across multiple domains of chemical biology and medicine. Its unique structural features enable diverse applications ranging from anticancer agents to bioelectrocatalysts. Continued exploration into its properties and functionalities will likely uncover new opportunities for therapeutic intervention and technological innovation.

• 128413-39-8(Guanidine, N-(2,6-dimethylphenyl)-N'-(2-methylphenyl)-)
• 124190-35-8(Guanidine, N-(4-amino-2-methylphenyl)-N'-(2-methylphenyl)-)
• 62577-36-0(Guanidine, N-(2,6-dimethylphenyl)-N-methyl-)
• 75535-12-5(Guanidine,N,N'-bis(dimethylphenyl)-)
• 90-70-0(Guanidine, N,N'-bis(2,3-dimethylphenyl)-)
• 93-69-6(1-(o-Tolyl)biguanide)
• 62577-37-1(Guanidine, N-(2,6-dimethylphenyl)-N'-methyl-)
• 97-39-2(Ditolylguanidine)
• 61705-84-8(Guanidine, (2-methylphenyl)-, hydrochloride)
• 6268-14-0(1-phenyl-3-o-tolylguanidine)